Steward Partners Investment Advisory, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$1,041
-93.8%
5,200
-36.6%
0.00%
Q2 2023$16,892
-37.6%
8,2000.0%0.00%
Q1 2023$27,060
+101.2%
8,2000.0%0.00%
Q4 2022$13,448
-62.6%
8,2000.0%0.00%
-100.0%
Q3 2022$36,000
+100.0%
8,200
+22.4%
0.00%
Q2 2022$18,000
-30.8%
6,700
-13.0%
0.00%
Q1 2022$26,000
-33.3%
7,700
-20.6%
0.00%
-100.0%
Q4 2021$39,000
-30.4%
9,700
-42.9%
0.00%0.0%
Q3 2021$56,000
-22.2%
17,000
-10.5%
0.00%0.0%
Q2 2021$72,000
-100.0%
19,000
-69.2%
0.00%
-50.0%
Q1 2021$235,928,000
+341824.6%
61,600
+302.6%
0.00%
+100.0%
Q4 2020$69,000
-84.0%
15,300
-39.8%
0.00%
-90.9%
Q3 2020$430,000
+54.7%
25,400
+2.4%
0.01%
+37.5%
Q2 2020$278,000
+212.4%
24,800
+28.5%
0.01%
+166.7%
Q1 2020$89,000
+535.7%
19,300
+451.4%
0.00%
Q4 2019$14,000
+55.6%
3,500
+40.0%
0.00%
Q3 2019$9,0000.0%2,5000.0%0.00%
Q2 2019$9,000
-60.9%
2,500
-58.3%
0.00%
-100.0%
Q3 2018$23,000
+155.6%
6,000
+100.0%
0.00%0.0%
Q1 2018$9,000
-18.2%
3,0000.0%0.00%0.0%
Q4 2017$11,0003,0000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders